✦ LIBER ✦

394 A phase I dose escalation and pharmacological study of the novel class I selective histone deacetylase inhibitor CHR-3996, in patients with advanced or treatment refractory solid tumours

✍ Scribed by F. Eskens; L. van Doorn; D. Papadatos-Pastos; P. Debnam; M. Tall; M. Toal; L. Hooftman; J. Verweij; U. Banerji

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, dose-escalation study of the

✍ Patrick Schöffski; Ahmad Awada; Herlinde Dumez; Thierry Gil; Sylvie Bartholomeus 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 245 KB

1245 POSTER Phase I Dose-escalation Stud

✍ G.S. Falchook; S. Fu; H.M. Amin; A.M. Tsimberdiou; D.S. Hong; A. Naing; M.B. Kle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

36 ORAL A Phase I single dose escalation

✍ P. Schöffski; A. Awada; H. Dumez; T. Gil; S. Bartholomeus; J. Selleslach; M. Tat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A phase I study of the safety and pharma

✍ Lassen, U; Molife, L R; Sorensen, M; Engelholm, S-A; Vidal, L; Sinha, R; Penson, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 316 KB

A phase I dose escalation study of the p

✍ Edwina N. Scott; Anne L. Thomas; L. Rhoda Molife; Samreen Ahmed; Sarah Blagden; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 253 KB

344 POSTER A phase Ib dose escalation st

✍ C. van Herpen; F. Eskens; M. de Jonge; I. Desar; L. Hooftman; E. Bone; A. Timmer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB